Nanalysis Appoints Dr. René Lenggenhager to Board of Directors

Stock Information for Nanalysis Scientific Corp.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Nanalysis Scientific Corp.

Nanalysis Announces Full Year 2023 Conference Call
Nanalysis Scientific Corp. Announces Director Resignation
Nanalysis Corp. Receives Funding Supporting AI Software Development for Detection of Illicit Substances
NANALYSIS ANNOUNCES CLOSING OF PREVIOUSLY ANNOUNCED BEST EFFORTS PROSPECTUS EXEMPT OFFERING PURSUANT TO THE LISTED ISSUER EXEMPTION AND CONCURRENT PRIVATE PLACEMENT
Canadian Investment Regulatory Organization Trade Resumption - NSCI
Canadian Investment Regulatory Organization Trading Halt - NSCI
NANALYSIS ANNOUNCES UP TO $5.0 MILLION BEST EFFORTS PROSPECTUS EXEMPT OFFERING PURSUANT TO THE LISTED ISSUER EXEMPTION AND UP TO $1.0 MILLION CONCURRENT PRIVATE PLACEMENT
Nanalysis Announces Upcoming Webinar and Conference Participation

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.